MedicalResearch.com: Interview with:
Anilkumar Pillai, Ph.D.
Associate Professor, Department of Psychiatry
Medical College of Georgia, Georgia Regents University
(
Formerly Georgia Health Sciences University)
Medical Research: What are the main findings of the study?
Dr. Pillai: GABA receptors are responsible for binding GABA, the main inhibitory neurotransmitter in the human brain. Recent studies have indicated a potential role for alterations in GABA
A receptors in the pathophysiology of Autism Spectrum Disorder (ASD). However, the mechanism of regulation of GABA
A receptor in Autism Spectrum Disorder is not known. Our study shows that GABA
A levels are altered at the protein level, but not at the mRNA level in the middle frontal gyrus of Autism Spectrum Disorder subjects. Our study also finds that Synoviolin 1 (SYVN1) plays a critical role as an E3 ligase in GABA
Aα1 degradation. SYVN1 has been previously determined to function as a removal system of inappropriately folded or unfolded proteins from the ER to the cytosol of the cell for degradation. Our study ultimately provides a mechanism for GABA
Aα1 deficits in
Autism Spectrum Disorder subjects and possible new treatment strategies to reverse deficits seen in ASD and other related disorders.
(more…)